{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:26:25Z","timestamp":1768530385485,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s12975-022-01107-3","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T07:53:41Z","timestamp":1669708421000},"page":"30-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of the New Thrombolytic Compound LT3001 on Acute Brain Tissue Damage After Focal Embolic Stroke in Rats"],"prefix":"10.1007","volume":"15","author":[{"given":"Yinghua","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris Yuwen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip Zhe","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingming","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron S.","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"issue":"4","key":"1107_CR1","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1161\/STROKEAHA.113.004362","volume":"45","author":"WN Whiteley","year":"2014","unstructured":"Whiteley WN, et al. Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial. Stroke. 2014;45(4):1000\u20136.","journal-title":"Stroke"},{"issue":"6","key":"1107_CR2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s12975-021-00916-2","volume":"12","author":"SH Yang","year":"2021","unstructured":"Yang SH, Liu R. Four decades of ischemic penumbra and its implication for ischemic stroke. Transl Stroke Res. 2021;12(6):937\u201345.","journal-title":"Transl Stroke Res"},{"issue":"2","key":"1107_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/01.STR.0000049764.49162.76","volume":"34","author":"GT Liberatore","year":"2003","unstructured":"Liberatore GT, et al. Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration. Stroke. 2003;34(2):537\u201343.","journal-title":"Stroke"},{"issue":"9","key":"1107_CR4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/01.WCB.0000137868.50767.E8","volume":"24","author":"J Kaur","year":"2004","unstructured":"Kaur J, et al. The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab. 2004;24(9):945\u201363.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"1107_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s12975-020-00872-3","volume":"12","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, et al. Diabetes mellitus\/poststroke hyperglycemia: a detrimental factor for tPA thrombolytic stroke therapy. Transl Stroke Res. 2021;12(3):416\u201327.","journal-title":"Transl Stroke Res"},{"issue":"8","key":"1107_CR6","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1038\/jcbfm.2009.61","volume":"29","author":"WM Armstead","year":"2009","unstructured":"Armstead WM, et al. Red blood cells-coupled tPA prevents impairment of cerebral vasodilatory responses and tissue injury in pediatric cerebral hypoxia\/ischemia through inhibition of ERK MAPK activation. J Cereb Blood Flow Metab. 2009;29(8):1463\u201374.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"1107_CR7","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1182\/blood-2003-05-1685","volume":"103","author":"T Nassar","year":"2004","unstructured":"Nassar T, et al. In vitro and in vivo effects of tPA and PAI-1 on blood vessel tone. Blood. 2004;103(3):897\u2013902.","journal-title":"Blood"},{"issue":"1","key":"1107_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/83358","volume":"7","author":"O Nicole","year":"2001","unstructured":"Nicole O, et al. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med. 2001;7(1):59\u201364.","journal-title":"Nat Med"},{"issue":"10","key":"1107_CR9","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/nm926","volume":"9","author":"X Wang","year":"2003","unstructured":"Wang X, et al. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med. 2003;9(10):1313\u20137.","journal-title":"Nat Med"},{"issue":"11 Suppl 1","key":"1107_CR10","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1161\/01.STR.0000143219.16695.af","volume":"35","author":"X Wang","year":"2004","unstructured":"Wang X, et al. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke. 2004;35(11 Suppl 1):2726\u201330.","journal-title":"Stroke"},{"issue":"3","key":"1107_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.tins.2003.12.011","volume":"27","author":"K Benchenane","year":"2004","unstructured":"Benchenane K, et al. Equivocal roles of tissue-type plasminogen activator in stroke-induced injury. Trends Neurosci. 2004;27(3):155\u201360.","journal-title":"Trends Neurosci"},{"issue":"4","key":"1107_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000098332","volume":"23","author":"N Zeevi","year":"2007","unstructured":"Zeevi N, et al. Acute stroke management in the elderly. Cerebrovasc Dis. 2007;23(4):304\u20138.","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"1107_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tins.2008.09.006","volume":"32","author":"M Yepes","year":"2009","unstructured":"Yepes M, et al. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends Neurosci. 2009;32(1):48\u201355.","journal-title":"Trends Neurosci"},{"issue":"11","key":"1107_CR14","first-page":"498","volume":"56","author":"N Akhtar","year":"2006","unstructured":"Akhtar N, Deleu D, Kamran S. Haematologic disorders and cerebral venous thrombosis. J Pak Med Assoc. 2006;56(11):498\u2013501.","journal-title":"J Pak Med Assoc"},{"key":"1107_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pneurobio.2016.09.002","volume":"145\u2013146","author":"MD Ginsberg","year":"2016","unstructured":"Ginsberg MD. Expanding the concept of neuroprotection for acute ischemic stroke: the pivotal roles of reperfusion and the collateral circulation. Prog Neurobiol. 2016;145\u2013146:46\u201377.","journal-title":"Prog Neurobiol"},{"issue":"10029","key":"1107_CR16","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal M, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723\u201331.","journal-title":"Lancet"},{"issue":"12","key":"1107_CR17","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1161\/STROKEAHA.117.017283","volume":"48","author":"SI Savitz","year":"2017","unstructured":"Savitz SI, et al. Reconsidering neuroprotection in the reperfusion era. Stroke. 2017;48(12):3413\u20139.","journal-title":"Stroke"},{"issue":"2","key":"1107_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5853\/jos.2017.02901","volume":"20","author":"A Chamorro","year":"2018","unstructured":"Chamorro A. Neuroprotectants in the era of reperfusion therapy. J Stroke. 2018;20(2):197\u2013207.","journal-title":"J Stroke"},{"issue":"1","key":"1107_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12975-019-00707-w","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, et al. Therapeutic role of a cysteine precursor, OTC, in ischemic stroke is mediated by improved proteostasis in mice. Transl Stroke Res. 2020;11(1):147\u201360.","journal-title":"Transl Stroke Res"},{"issue":"5","key":"1107_CR20","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1161\/STROKEAHA.118.020711","volume":"49","author":"A Taskiran-Sag","year":"2018","unstructured":"Taskiran-Sag A, et al. Improving microcirculatory reperfusion reduces parenchymal oxygen radical formation and provides neuroprotection. Stroke. 2018;49(5):1267\u201375.","journal-title":"Stroke"},{"issue":"4","key":"1107_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1177\/1747493016684354","volume":"12","author":"A Chamorro","year":"2017","unstructured":"Chamorro A, et al. Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy. Int J Stroke. 2017;12(4):377\u201382.","journal-title":"Int J Stroke"},{"issue":"11","key":"1107_CR22","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1161\/STROKEAHA.116.014672","volume":"47","author":"S Amaro","year":"2016","unstructured":"Amaro S, et al. Uric acid therapy prevents early ischemic stroke progression: a tertiary analysis of the URICO-ICTUS Trial (Efficacy Study of Combined Treatment With Uric Acid and r-tPA in Acute Ischemic Stroke). Stroke. 2016;47(11):2874\u20136.","journal-title":"Stroke"},{"issue":"4","key":"1107_CR23","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.10.011","volume":"26","author":"T Yamaguchi","year":"2017","unstructured":"Yamaguchi T, et al. Edaravone with and without .6 Mg\/Kg alteplase within 4.5 hours after ischemic stroke: a prospective cohort study (PROTECT4.5). J Stroke Cerebrovasc Dis. 2017;26(4):756\u201365.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"1107_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/187152708784936635","volume":"7","author":"X Wang","year":"2008","unstructured":"Wang X, Rosell A, Lo EH. Targeting extracellular matrix proteolysis for hemorrhagic complications of tPA stroke therapy. CNS Neurol Disord: Drug Targets. 2008;7(3):235\u201342.","journal-title":"CNS Neurol Disord: Drug Targets"},{"issue":"9","key":"1107_CR25","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/j.bmc.2004.02.011","volume":"12","author":"M Zhao","year":"2004","unstructured":"Zhao M, et al. The composition and sequence specificity of Pro-Ala-Lys-OH for the thrombolytic activities of P6A and related oligopeptides. Bioorg Med Chem. 2004;12(9):2275\u201386.","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"1107_CR26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s12975-017-0542-6","volume":"8","author":"X Fan","year":"2017","unstructured":"Fan X, et al. Annexin A2 plus low-dose tissue plasminogen activator combination attenuates cerebrovascular dysfunction after focal embolic stroke of rats. Transl Stroke Res. 2017;8(6):549\u201359.","journal-title":"Transl Stroke Res"},{"issue":"6","key":"1107_CR27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s12975-019-0687-6","volume":"10","author":"L Wang","year":"2019","unstructured":"Wang L, et al. Dynamic detection of thrombolysis in embolic stroke rats by synchrotron radiation angiography. Transl Stroke Res. 2019;10(6):695\u2013704.","journal-title":"Transl Stroke Res"},{"key":"1107_CR28","doi-asserted-by":"publisher","unstructured":"Matur AV, et al. Translating animal models of ischemic stroke to the human condition. Transl Stroke Res. 2022. https:\/\/doi.org\/10.1007\/s12975-022-01082-9.","DOI":"10.1007\/s12975-022-01082-9"},{"issue":"2","key":"1107_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1055\/s-0038-1653411","volume":"46","author":"C Korninger","year":"1981","unstructured":"Korninger C, Collen D. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro. Thromb Haemost. 1981;46(2):561\u20135.","journal-title":"Thromb Haemost"},{"issue":"6","key":"1107_CR30","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1161\/STROKEAHA.108.541128","volume":"40","author":"M Fisher","year":"2009","unstructured":"Fisher M, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke: J Cereb Circ. 2009;40(6):2244\u201350.","journal-title":"Stroke: J Cereb Circ"},{"issue":"3","key":"1107_CR31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12975-012-0209-2","volume":"4","author":"PA Lapchak","year":"2013","unstructured":"Lapchak PA, Zhang JH, Noble-Haeusslein LJ. RIGOR guidelines: escalating STAIR and STEPS for effective translational research. Transl Stroke Res. 2013;4(3):279\u201385.","journal-title":"Transl Stroke Res"},{"key":"1107_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neulet.2015.06.050","volume":"602","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, et al. Low dose tPA plus annexin A2 combination attenuates tPA delayed treatment-associated hemorrhage and improves recovery in rat embolic focal stroke. Neurosci Lett. 2015;602:73\u20138.","journal-title":"Neurosci Lett"},{"key":"1107_CR33","doi-asserted-by":"publisher","unstructured":"Kang R, et al. Three days delayed recanalization improved neurological function in pMCAO rats by increasing M2 microglia-possible involvement of the IL-4R\/STAT6\/PPARgamma pathway. Transl Stroke Res. 2022. https:\/\/doi.org\/10.1007\/s12975-022-01032-5.","DOI":"10.1007\/s12975-022-01032-5"},{"key":"1107_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mrm.1910330107","volume":"33","author":"S Mori","year":"1995","unstructured":"Mori S, van Zijl PCM. Diffusion weighting by the trace of the diffusion tensor within a single scan. Magn Reson Med. 1995;33:41\u201352.","journal-title":"Magn Reson Med"},{"issue":"1","key":"1107_CR35","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/mrm.27419","volume":"81","author":"Y Ji","year":"2019","unstructured":"Ji Y, et al. In vivo microscopic diffusional kurtosis imaging with symmetrized double diffusion encoding EPI. Magn Reson Med. 2019;81(1):533\u201341.","journal-title":"Magn Reson Med"},{"issue":"2","key":"1107_CR36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/nbm.1729","volume":"25","author":"JS Cheung","year":"2012","unstructured":"Cheung JS, et al. Fast radio-frequency enforced steady state (FRESS) spin echo MRI for quantitative T2 mapping: minimizing the apparent repetition time (TR) dependence for fast T2 measurement. NMR Biomed. 2012;25(2):189\u201394.","journal-title":"NMR Biomed"},{"issue":"2","key":"1107_CR37","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1148\/radiology.208.2.9680569","volume":"208","author":"DC Alsop","year":"1998","unstructured":"Alsop DC, Detre JA. Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology. 1998;208(2):410\u20136.","journal-title":"Radiology"},{"issue":"3","key":"1107_CR38","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/mrm.28510","volume":"85","author":"Y Ji","year":"2021","unstructured":"Ji Y, et al. Development of fast multi-slice apparent T1 mapping for improved arterial spin labeling MRI measurement of cerebral blood flow. Magn Reson Med. 2021;85(3):1571\u201380.","journal-title":"Magn Reson Med"},{"issue":"1","key":"1107_CR39","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1073\/pnas.89.1.212","volume":"89","author":"DS Williams","year":"1992","unstructured":"Williams DS, et al. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A. 1992;89(1):212\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1107_CR40","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.measurement.2010.03.013","volume":"43","author":"L-H Juang","year":"2010","unstructured":"Juang L-H, Wu M-N. MRI brain lesion image detection based on color-converted K-means clustering segmentation. Measurement. 2010;43(7):941\u20139.","journal-title":"Measurement"},{"issue":"5","key":"1107_CR41","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s12975-020-00884-z","volume":"12","author":"KR Nalamolu","year":"2021","unstructured":"Nalamolu KR, et al. Attenuation of the induction of TLRs 2 and 4 mitigates inflammation and promotes neurological recovery after focal cerebral ischemia. Transl Stroke Res. 2021;12(5):923\u201336.","journal-title":"Transl Stroke Res"},{"issue":"6","key":"1107_CR42","doi-asserted-by":"publisher","first-page":"H806","DOI":"10.1152\/ajpheart.00720.2012","volume":"304","author":"AI Kelly-Cobbs","year":"2013","unstructured":"Kelly-Cobbs AI, et al. Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes. Am J Physiol Heart Circ Physiol. 2013;304(6):H806\u201315.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"1107_CR43","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1161\/STROKEAHA.111.635250","volume":"43","author":"X Fan","year":"2012","unstructured":"Fan X, et al. A rat model of studying tissue-type plasminogen activator thrombolysis in ischemic stroke with diabetes. Stroke: J Cereb Circ. 2012;43(2):567\u201370.","journal-title":"Stroke: J Cereb Circ"},{"issue":"6","key":"1107_CR44","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/jcbfm.2009.279","volume":"30","author":"H Zhu","year":"2010","unstructured":"Zhu H, et al. Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke. J Cereb Blood Flow Metab. 2010;30(6):1137\u201346.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"1107_CR45","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/jcbfm.2009.279","volume":"30","author":"H Zhu","year":"2010","unstructured":"Zhu H, et al. Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke. J Cereb Blood Flow Metab. 2010;30(6):1137\u201346.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"1107_CR46","first-page":"153","volume":"110","author":"L Sun","year":"2013","unstructured":"Sun L, et al. Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia. Thromb Haemost. 2013;110(1):153\u201361.","journal-title":"Thromb Haemost"},{"issue":"10","key":"1107_CR47","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1161\/STROKEAHA.111.622217","volume":"43","author":"A Tjarnlund-Wolf","year":"2012","unstructured":"Tjarnlund-Wolf A, et al. Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases. Stroke. 2012;43(10):2833\u20139.","journal-title":"Stroke"},{"key":"1107_CR48","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fneur.2018.00327","volume":"9","author":"MR Etherton","year":"2018","unstructured":"Etherton MR, et al. Neuroimaging paradigms to identify patients for reperfusion therapy in stroke of unknown onset. Front Neurol. 2018;9:327.","journal-title":"Front Neurol"},{"issue":"10154","key":"1107_CR49","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S0140-6736(18)31874-9","volume":"392","author":"C Zerna","year":"2018","unstructured":"Zerna C, et al. Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke. Lancet. 2018;392(10154):1247\u201356.","journal-title":"Lancet"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-022-01107-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-022-01107-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-022-01107-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T11:49:32Z","timestamp":1705578572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-022-01107-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1107"],"URL":"https:\/\/doi.org\/10.1007\/s12975-022-01107-3","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]},"assertion":[{"value":"17 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no competing interests. LT3001 was provided from the Lumosa Therapeutics Co. Ltd, Taiwan (licensed by the USA patent-US2016\/0083423A1).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All data generated or analyzed during this study are included in this published article (and its supplementary information files).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}}]}}